Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
IWS1	55677	broad.mit.edu	37	2	128252455	128252455	+	Missense_Mutation	SNP	G	G	A			STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	g.chr2:128252455G>A	ENST00000295321.4	-	8	2051	c.1792C>T	c.(1792-1794)Ctt>Ttt	p.L598F	IWS1_ENST00000455721.2_3'UTR|AC010976.2_ENST00000599001.1_RNA	NM_017969.2	NP_060439.2	Q96ST2	IWS1_HUMAN	IWS1 homolog (S. cerevisiae)	598		NA			transcription, DNA-dependent	nucleus	DNA binding			cervix(1)|endometrium(2)|kidney(6)|large_intestine(2)|lung(12)|ovary(1)|prostate(1)|skin(2)|urinary_tract(1)	28	Colorectal(110;0.1)			BRCA - Breast invasive adenocarcinoma(221;0.0735)		TACTTCTTAAGGTGCATAACT	0.284		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													77	82	80			NA	NA	2		NA											NA				128252455		2201	4284	6485	SO:0001583	missense			ENSG00000163166	HGNC:25467	NM_017969	Approved	uc002ton.2	NA	Q2TB65|Q6P157|Q8N3E8|Q96MI7|Q9NV97|Q9NWH8	ENST00000295321.4	37	CCDS2146.1	.	.	.	.	.	.	.	.	.	.	G	26.7	4.758431	0.89843	.	.	ENSG00000163166	ENST00000295321;ENST00000433551	T	0.51817	0.69	5.82	5.82	0.92795	.	0.000000	0.85682	D	0.000000	T	0.74809	0.3765	M	0.86651	2.83	0.80722	D	1	D	0.89917	1.0	D	0.76575	0.988	T	0.77472	-0.2575	10	0.62326	D	0.03	-10.7852	20.0992	0.97865	0.0:0.0:1.0:0.0	.	598	Q96ST2	IWS1_HUMAN	F	598;551	ENSP00000295321:L598F	ENSP00000295321:L598F	L	-	1	0	IWS1	127968925	1.000000	0.71417	1.000000	0.80357	0.880000	0.50808	6.648000	0.74359	2.762000	0.94881	0.467000	0.42956	CTT	IWS1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000254384.2	31.883418	KEEP		-	33.313529	0.3	12	28	---	---	---	---	1	0.999998	160	271	4	283	12	31	0	73	24	TP
HDAC4	9759	broad.mit.edu	37	2	240056254	240056254	+	Missense_Mutation	SNP	G	G	A			STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	g.chr2:240056254G>A	ENST00000345617.3	-	10	1855	c.1064C>T	c.(1063-1065)aCg>aTg	p.T355M	HDAC4_ENST00000553145.1_5'UTR|HDAC4_ENST00000543185.1_De_novo_Start_InFrame|HDAC4_ENST00000541256.1_Missense_Mutation_p.T324M	NM_006037.3	NP_006028.2	P56524	HDAC4_HUMAN	histone deacetylase 4	355		NA			B cell differentiation|cardiac muscle hypertrophy in response to stress|chromatin remodeling|histone H3 deacetylation|histone H4 deacetylation|inflammatory response|negative regulation of glycolysis|negative regulation of myotube differentiation|negative regulation of sequence-specific DNA binding transcription factor activity|negative regulation of transcription from RNA polymerase II promoter|nervous system development|peptidyl-lysine deacetylation|positive regulation of cell proliferation|positive regulation of protein sumoylation|positive regulation of sequence-specific DNA binding transcription factor activity|positive regulation of transcription from RNA polymerase II promoter|regulation of protein binding|response to denervation involved in regulation of muscle adaptation|response to interleukin-1|transcription, DNA-dependent	histone deacetylase complex|transcriptional repressor complex	activating transcription factor binding|histone deacetylase activity (H3-K16 specific)|histone deacetylase binding|NAD-dependent histone deacetylase activity (H3-K14 specific)|NAD-dependent histone deacetylase activity (H3-K9 specific)|NAD-dependent histone deacetylase activity (H4-K16 specific)|potassium ion binding|repressing transcription factor binding|zinc ion binding			NS(1)|biliary_tract(1)|breast(4)|endometrium(5)|kidney(2)|large_intestine(7)|lung(27)|ovary(3)|pancreas(1)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(5)	62		all_epithelial(40;1.45e-17)|Breast(86;1.53e-05)|Renal(207;0.000355)|all_lung(227;0.0121)|Ovarian(221;0.0183)|Lung NSC(271;0.0413)|Melanoma(123;0.0749)|all_hematologic(139;0.159)		Epithelial(121;6.38e-25)|OV - Ovarian serous cystadenocarcinoma(60;2.48e-12)|Kidney(56;6.04e-08)|KIRC - Kidney renal clear cell carcinoma(57;1.18e-06)|BRCA - Breast invasive adenocarcinoma(100;3.99e-05)|Lung(119;0.00942)|LUSC - Lung squamous cell carcinoma(224;0.04)		CAGGCCCAGCGTGATGTTGGG	0.647		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													102	104	104			NA	NA	2		NA											NA				240056254		2203	4300	6503	SO:0001583	missense			ENSG00000068024	HGNC:14063	NM_006037	Approved	uc002vyk.4	NA	Q9UND6	ENST00000345617.3	37	CCDS2529.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	G|G	18.29|18.29	3.591817|3.591817	0.66219|0.66219	.|.	.|.	ENSG00000068024|ENSG00000068024	ENST00000445704|ENST00000345617;ENST00000456922;ENST00000541256;ENST00000393621	.|T;T	.|0.61392	.|0.11;1.23	4.32|4.32	4.32|4.32	0.51571|0.51571	.|.	.|0.000000	.|0.85682	.|D	.|0.000000	T|T	0.77267|0.77267	0.4105|0.4105	M|M	0.81497|0.81497	2.545|2.545	0.80722|0.80722	D|D	1|1	.|D;D;D;D;D;D	.|0.89917	.|1.0;1.0;1.0;1.0;1.0;1.0	.|D;D;D;D;D;D	.|0.91635	.|0.987;0.996;0.997;0.999;0.98;0.999	T|T	0.79931|0.79931	-0.1595|-0.1595	5|9	.|.	.|.	.|.	.|.	17.7023|17.7023	0.88299|0.88299	0.0:0.0:1.0:0.0|0.0:0.0:1.0:0.0	.|.	.|350;238;324;324;323;355	.|B7Z8G5;F5H0Q9;F5H5W4;B7Z8I2;Q53SM2;P56524	.|.;.;.;.;.;HDAC4_HUMAN	C|M	99|355;238;324;238	.|ENSP00000264606:T355M;ENSP00000443057:T324M	.|.	R|T	-|-	1|2	0|0	HDAC4|HDAC4	239721191|239721191	1.000000|1.000000	0.71417|0.71417	0.938000|0.938000	0.37757|0.37757	0.162000|0.162000	0.22319|0.22319	9.277000|9.277000	0.95755|0.95755	2.339000|2.339000	0.79563|0.79563	0.561000|0.561000	0.74099|0.74099	CGC|ACG	HDAC4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000257174.2	69.125737	KEEP		-	69.23124	0.45098	23	28	---	---	---	---	1	1	485	725	0	922	26	28	0	81	2	TP
PTPN23	25930	broad.mit.edu	37	3	47453790	47453790	+	Missense_Mutation	SNP	C	C	T			STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	g.chr3:47453790C>T	ENST00000265562.4	+	23	4273	c.4196C>T	c.(4195-4197)aCg>aTg	p.T1399M	PTPN23_ENST00000431726.1_Missense_Mutation_p.T1273M	NM_015466.2	NP_056281.1	Q9H3S7	PTN23_HUMAN	protein tyrosine phosphatase, non-receptor type 23	1399	Tyrosine-protein phosphatase.	NA			cilium morphogenesis	cilium|cytoplasmic membrane-bounded vesicle|microtubule basal body	protein tyrosine phosphatase activity			breast(3)|central_nervous_system(1)|large_intestine(5)|lung(7)|prostate(2)|skin(4)|upper_aerodigestive_tract(1)	23				BRCA - Breast invasive adenocarcinoma(193;0.000271)|KIRC - Kidney renal clear cell carcinoma(197;0.00558)|Kidney(197;0.00632)		GTGGGCCGCACGGGAGCCTTT	0.632		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													67	72	70			NA	NA	3		NA											NA				47453790		2203	4300	6503	SO:0001583	missense			ENSG00000076201	HGNC:14406	NM_015466	Approved	uc003crf.1	NA	A8K0D7|Q7KZF8|Q8N6Z5|Q9BSR5|Q9P257|Q9UG03|Q9UMZ4	ENST00000265562.4	37	CCDS2754.1	.	.	.	.	.	.	.	.	.	.	C	18.17	3.564082	0.65651	.	.	ENSG00000076201	ENST00000265562	T	0.26660	1.72	3.99	3.99	0.46301	Protein-tyrosine phosphatase, receptor/non-receptor type (4);Protein-tyrosine/Dual-specificity phosphatase (1);	0.063405	0.64402	D	0.000009	T	0.64702	0.2622	H	0.97682	4.055	0.54753	D	0.999981	D	0.89917	1.0	D	0.70227	0.968	T	0.79664	-0.1709	10	0.87932	D	0	-13.0055	15.0391	0.71774	0.0:1.0:0.0:0.0	.	1399	Q9H3S7	PTN23_HUMAN	M	1399	ENSP00000265562:T1399M	ENSP00000265562:T1399M	T	+	2	0	PTPN23	47428794	1.000000	0.71417	0.986000	0.45419	0.762000	0.43233	7.187000	0.77730	2.045000	0.60652	0.563000	0.77884	ACG	PTPN23-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000257492.2	102.74412	KEEP		+	105.348268	0.336364	37	73	---	---	---	---	1	1	150	279	0	275	45	78	0	174	2	TP
IMPG2	50939	broad.mit.edu	37	3	100964796	100964796	+	Missense_Mutation	SNP	C	C	T			STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	g.chr3:100964796C>T	ENST00000193391.7	-	12	1580	c.1393G>A	c.(1393-1395)Gcc>Acc	p.A465T		NM_016247.3	NP_057331.2	Q9BZV3	IMPG2_HUMAN	interphotoreceptor matrix proteoglycan 2	465		NA			visual perception	integral to membrane|proteinaceous extracellular matrix	extracellular matrix structural constituent|heparin binding|hyaluronic acid binding|receptor activity			NS(1)|breast(2)|cervix(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(3)|kidney(2)|large_intestine(14)|lung(32)|ovary(2)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	64						GAGGGAAAGGCTAATTTGTGT	0.507		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													108	111	110			NA	NA	3		NA											NA				100964796		2203	4300	6503	SO:0001583	missense			ENSG00000081148	HGNC:18362		Approved	uc003duq.2	NA	A8MWT5|Q9UKD4|Q9UKK5	ENST00000193391.7	37	CCDS2940.1	.	.	.	.	.	.	.	.	.	.	C	5.079	0.200191	0.09652	.	.	ENSG00000081148	ENST00000193391	T	0.23147	1.92	5.87	1.88	0.25563	.	0.912271	0.09467	N	0.798123	T	0.15955	0.0384	L	0.29908	0.895	0.09310	N	1	B;B	0.22346	0.068;0.068	B;B	0.13407	0.009;0.009	T	0.20306	-1.0279	10	0.46703	T	0.11	-0.2065	3.1532	0.06495	0.1324:0.3227:0.4016:0.1433	.	465;465	F1T0J3;Q9BZV3	.;IMPG2_HUMAN	T	465	ENSP00000193391:A465T	ENSP00000193391:A465T	A	-	1	0	IMPG2	102447486	0.994000	0.37717	0.944000	0.38274	0.949000	0.60115	0.229000	0.17833	1.444000	0.47605	0.655000	0.94253	GCC	IMPG2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000353256.3	81.582068	KEEP		-	85.228183	0.300971	31	72	---	---	---	---	1	1	425	851	0	811	33	75	0	117	2	TP
PIK3CA	5290	broad.mit.edu	37	3	178936091	178936091	+	Missense_Mutation	SNP	G	G	A	rs104886003		STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	g.chr3:178936091G>A	ENST00000263967.3	+	10	1790	c.1633G>A	c.(1633-1635)Gag>Aag	p.E545K		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	545	PI3K helical.	NA	E -> A (in cancer).|E -> G (in KERSEB).|E -> K (in KERSEB; shows an increase in lipid kinase activity; oncogenic in vivo; occurs in the interface between the PI3K helical domain and the nSH2 (N-terminal SH2) region of the p85 regulatory subunit and may reduce the inhibitory effect of p85; requires interaction with RAS to induce cellular transformation; enhances invadopodia-mediated extracellular matrix degradation and invasion in breast cancer cells).		epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway		1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity	p.E545K(881)|p.E545Q(18)		NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)			TGAAATCACTGAGCAGGAGAA	0.353	E545K(BC3C_URINARY_TRACT)|E545K(BFTC909_KIDNEY)|E545K(DLD1_LARGE_INTESTINE)|E545K(ESS1_ENDOMETRIUM)|E545K(HCC202_BREAST)|E545K(HCT15_LARGE_INTESTINE)|E545K(HSC4_UPPER_AERODIGESTIVE_TRACT)|E545K(HT1197_URINARY_TRACT)|E545K(HUH28_BILIARY_TRACT)|E545K(KYSE510_OESOPHAGUS)|E545K(L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|E545K(MCF7_BREAST)|E545K(MDAMB361_BREAST)|E545K(MKN1_STOMACH)|E545K(NCIH460_LUNG)|E545K(NCIH508_LARGE_INTESTINE)|E545K(NCIH596_LUNG)|E545K(RERFLCSQ1_LUNG)|E545K(TCCSUP_URINARY_TRACT)|E545K(TE5_OESOPHAGUS)	57	Mis		"""colorectal, gastric, gliobastoma, breast"""					HNSCC(19;0.045)|TSP Lung(28;0.18)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3	3q26.3	5290	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""		"""E, O"""	899	Substitution - Missense(899)	breast(308)|large_intestine(286)|urinary_tract(97)|lung(44)|endometrium(37)|ovary(25)|stomach(17)|upper_aerodigestive_tract(16)|skin(14)|central_nervous_system(13)|cervix(13)|thyroid(7)|oesophagus(7)|penis(4)|kidney(3)|soft_tissue(2)|pancreas(2)|haematopoietic_and_lymphoid_tissue(1)|biliary_tract(1)|NS(1)|pituitary(1)											61	60	60			NA	NA	3		NA											NA				178936091		1813	4072	5885	SO:0001583	missense			ENSG00000121879	HGNC:8975		Approved	uc003fjk.3	NA	Q14CW1|Q99762	ENST00000263967.3	37	CCDS43171.1	.	.	.	.	.	.	.	.	.	.	G	36	5.703347	0.96812	.	.	ENSG00000121879	ENST00000263967	T	0.63255	-0.03	5.78	5.78	0.91487	Phosphoinositide 3-kinase, accessory (PIK) domain (3);Armadillo-type fold (1);	0.000000	0.85682	D	0.000000	T	0.73822	0.3636	L	0.51914	1.62	0.80722	D	1	D	0.62365	0.991	D	0.62955	0.909	T	0.68872	-0.5294	10	0.32370	T	0.25	-25.7963	20.0024	0.97423	0.0:0.0:1.0:0.0	.	545	P42336	PK3CA_HUMAN	K	545	ENSP00000263967:E545K	ENSP00000263967:E545K	E	+	1	0	PIK3CA	180418785	1.000000	0.71417	1.000000	0.80357	0.951000	0.60555	9.476000	0.97823	2.722000	0.93159	0.467000	0.42956	GAG	PIK3CA-001	KNOWN	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348409.2	36.664656	KEEP		+	41.394818	0.228571	16	54	---	---	---	---	1	1	345	919	2	888	16	57	0	66	10	TP
PGM5	5239	broad.mit.edu	37	9	71002450	71002450	+	Missense_Mutation	SNP	G	G	T	rs146547812	by1000genomes	STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	g.chr9:71002450G>T	ENST00000396396.1	+	4	872	c.643G>T	c.(643-645)Ggt>Tgt	p.G215C	PGM5_ENST00000396392.1_Missense_Mutation_p.G215C|PGM5_ENST00000604870.2_3'UTR	NM_021965.3	NP_068800.2	Q15124	PGM5_HUMAN	phosphoglucomutase 5	215		NA			cell adhesion|cellular calcium ion homeostasis|glucose metabolic process	costamere|dystrophin-associated glycoprotein complex|focal adhesion|intercalated disc|internal side of plasma membrane|sarcolemma|spot adherens junction|stress fiber|Z disc	intramolecular transferase activity, phosphotransferases|magnesium ion binding|structural molecule activity			endometrium(5)|kidney(1)|large_intestine(5)|liver(2)|lung(15)|ovary(1)|pancreas(1)|prostate(3)|skin(1)	34						TGCCATCAAGGGTTTGCTGAC	0.438		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													137	125	129			NA	NA	9		NA											NA				71002450		2203	4299	6502	SO:0001583	missense			ENSG00000154330	HGNC:8908	NM_021965	Approved	uc004agr.3	NA	B1AM46|B4DLQ6|Q5VYV3|Q8N527|Q9UDH4	ENST00000396396.1	37	CCDS6622.2	.	.	.	.	.	.	.	.	.	.	.	16.21	3.057459	0.55325	.	.	ENSG00000154330	ENST00000396396;ENST00000396392;ENST00000377314;ENST00000431583	T;T;T	0.64260	-0.09;-0.09;-0.09	5.03	2.67	0.31697	Alpha-D-phosphohexomutase, alpha/beta/alpha I/II/III (2);Alpha-D-phosphohexomutase, alpha/beta/alpha domain II (1);	0.089946	0.85682	U	0.000000	T	0.66528	0.2798	L	0.55213	1.73	0.20307	N	0.999918	P	0.47841	0.901	P	0.55545	0.778	T	0.58973	-0.7541	10	0.72032	D	0.01	.	8.3557	0.32329	0.7622:0.0:0.2378:0.0	.	215	Q15124	PGM5_HUMAN	C	215;215;166;132	ENSP00000379678:G215C;ENSP00000379674:G215C;ENSP00000394864:G132C	ENSP00000366531:G166C	G	+	1	0	PGM5	70192270	1.000000	0.71417	0.999000	0.59377	0.759000	0.43091	1.914000	0.39966	-0.006000	0.14370	-0.529000	0.04317	GGT	PGM5-001	KNOWN	not_organism_supported|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000052548.2	100.922913	KEEP		+	102.673521	0.357143	35	63	---	---	---	---	1	1	160	837	0	317	37	65	0	107	2	TP
VPS13A	23230	broad.mit.edu	37	9	79824434	79824434	+	Missense_Mutation	SNP	C	C	T			STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	g.chr9:79824434C>T	ENST00000360280.3	+	6	741	c.481C>T	c.(481-483)Cgt>Tgt	p.R161C	VPS13A_ENST00000376636.3_Missense_Mutation_p.R161C|VPS13A_ENST00000357409.5_Missense_Mutation_p.R161C|VPS13A_ENST00000376634.4_Missense_Mutation_p.R161C	NM_033305.2	NP_150648.2	Q96RL7	VP13A_HUMAN	vacuolar protein sorting 13 homolog A (S. cerevisiae)	161		NA	R -> H (in a colorectal cancer sample; somatic mutation).		Golgi to endosome transport|protein transport	intracellular	protein binding			breast(4)|central_nervous_system(1)|cervix(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(2)|kidney(1)|large_intestine(28)|liver(1)|lung(42)|ovary(3)|pancreas(3)|prostate(3)|skin(9)|upper_aerodigestive_tract(1)|urinary_tract(1)	104						TATCCATATTCGTTATGAAGA	0.274		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													33	34	33			NA	NA	9		NA											NA				79824434		2200	4291	6491	SO:0001583	missense			ENSG00000197969	HGNC:1908	NM_015186	Approved	uc004akr.3	NA	Q5JSX9|Q5JSY0|Q5VYR5|Q702P4|Q709D0|Q86YF8|Q96S61|Q9H995|Q9Y2J1	ENST00000360280.3	37	CCDS6655.1	.	.	.	.	.	.	.	.	.	.	C	23.8	4.457105	0.84317	.	.	ENSG00000197969	ENST00000376634;ENST00000376636;ENST00000360280;ENST00000357409	T;T;T;T	0.67865	-0.14;-0.29;-0.24;-0.15	5.71	4.81	0.61882	.	0.000000	0.85682	D	0.000000	D	0.84906	0.5576	M	0.91561	3.22	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;0.999;1.0;1.0	D	0.88380	0.3001	10	0.87932	D	0	.	14.2793	0.66200	0.0:0.9276:0.0:0.0724	.	161;161;161;161	Q96RL7-3;Q96RL7;Q96RL7-2;Q96RL7-4	.;VP13A_HUMAN;.;.	C	161	ENSP00000365821:R161C;ENSP00000365823:R161C;ENSP00000353422:R161C;ENSP00000349985:R161C	ENSP00000349985:R161C	R	+	1	0	VPS13A	79014254	1.000000	0.71417	0.999000	0.59377	0.993000	0.82548	7.182000	0.77689	1.417000	0.47077	0.655000	0.94253	CGT	VPS13A-005	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000052753.2	24.766151	KEEP		+	25.6943	0.310345	9	20	---	---	---	---	1	0.9952167	12	16	0	25	9	22	0	30	2	TP
KRAS	3845	broad.mit.edu	37	12	25398281	25398281	+	Missense_Mutation	SNP	C	C	T	rs112445441		STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	g.chr12:25398281C>T	ENST00000311936.3	-	2	229	c.38G>A	c.(37-39)gGc>gAc	p.G13D	KRAS_ENST00000256078.4_Missense_Mutation_p.G13D|KRAS_ENST00000557334.1_Missense_Mutation_p.G13D|KRAS_ENST00000556131.1_Missense_Mutation_p.G13D	NM_004985.3	NP_004976.2	P01116	RASK_HUMAN	Kirsten rat sarcoma viral oncogene homolog	13		NA	G -> D (in a breast carcinoma cell line and GASC; somatic mutation).|G -> R (in pylocytic astrocytoma; somatic mutation; increase activation of the Ras pathway).		activation of MAPKK activity|axon guidance|blood coagulation|epidermal growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|Ras protein signal transduction	plasma membrane	GTP binding|GTPase activity|protein binding	p.G13D(3223)|p.G13V(33)|p.G13A(28)|p.G13E(3)|p.G13I(1)|p.G13N(1)|p.G13_V14>DI(1)|p.G13R(1)	UBE2L3/KRAS(2)	NS(6)|adrenal_gland(1)|autonomic_ganglia(3)|biliary_tract(532)|bone(2)|breast(32)|central_nervous_system(14)|cervix(50)|endometrium(411)|eye(4)|gastrointestinal_tract_(site_indeterminate)(7)|genital_tract(1)|haematopoietic_and_lymphoid_tissue(385)|kidney(8)|large_intestine(15267)|liver(29)|lung(3407)|oesophagus(16)|ovary(612)|pancreas(3739)|penis(1)|peritoneum(6)|prostate(96)|salivary_gland(6)|skin(45)|small_intestine(68)|soft_tissue(88)|stomach(207)|testis(17)|thymus(5)|thyroid(159)|upper_aerodigestive_tract(68)|urinary_tract(57)	25349	all_cancers(2;1e-35)|all_epithelial(2;1.97e-38)|all_lung(3;2.1e-23)|Lung NSC(3;1.16e-22)|Acute lymphoblastic leukemia(6;0.00231)|all_hematologic(7;0.00259)|Melanoma(3;0.0301)|Colorectal(261;0.11)|Ovarian(17;0.12)		OV - Ovarian serous cystadenocarcinoma(3;1.23e-21)|Epithelial(3;1.31e-20)|all cancers(3;5.45e-18)|STAD - Stomach adenocarcinoma(2;2.68e-05)			CTTGCCTACGCCACCAGCTCC	0.338	G13D(DLD1_LARGE_INTESTINE)|G13D(DV90_LUNG)|G13D(HCT116_LARGE_INTESTINE)|G13D(HCT15_LARGE_INTESTINE)|G13D(LOVO_LARGE_INTESTINE)|G13D(MDAMB231_BREAST)|G13D(NCIH647_LUNG)|G13D(NCIH747_LARGE_INTESTINE)|G13D(NOMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|G13D(T84_LARGE_INTESTINE)|G13D(TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)	119	Mis		"""pancreatic, colorectal, lung, thyroid, AML, others"""				Noonan syndrome;Cardiofaciocutaneous syndrome	TSP Lung(1;<1E-08)|Multiple Myeloma(2;<1E-6)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(8;6 143 191 305 2070 2426 4376 10944 11745 26467 38091 50869)		Dom	yes		12	12p12.1	3845	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog		"""L, E, M, O"""	3291	Substitution - Missense(3290)|Complex - compound substitution(1)	large_intestine(2808)|haematopoietic_and_lymphoid_tissue(94)|lung(92)|endometrium(54)|soft_tissue(38)|ovary(38)|stomach(32)|pancreas(30)|thyroid(27)|biliary_tract(21)|prostate(20)|breast(10)|cervix(4)|gastrointestinal_tract_(site_indeterminate)(3)|upper_aerodigestive_tract(3)|urinary_tract(3)|liver(3)|salivary_gland(3)|small_intestine(3)|oesophagus(2)|skin(1)|genital_tract(1)|bone(1)											88	78	82			NA	NA	12		NA											NA				25398281		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Male Turner syndrome, Pterygium Colli syndrome, incl. Noonan-like/Multiple Giant Cell Lesion syndrome; Noonan s. with multiple lentigines/LEOPARD syndrome;CFC, CFCS	ENSG00000133703	HGNC:6407	NM_033360	Approved	uc001rgp.1	NA	A8K8Z5|B0LPF9|P01118|Q96D10	ENST00000311936.3	37	CCDS8702.1	.	.	.	.	.	.	.	.	.	.	C	27.8	4.867862	0.91587	.	.	ENSG00000133703	ENST00000311936;ENST00000557334;ENST00000256078;ENST00000556131	D;T;T;T	0.82803	-1.65;-0.7;-0.7;-0.7	5.68	5.68	0.88126	Small GTP-binding protein domain (1);	0.000000	0.85682	D	0.000000	D	0.90079	0.6901	M	0.93062	3.375	0.80722	D	1	B;P	0.43314	0.215;0.803	B;P	0.46172	0.175;0.506	D	0.92106	0.5692	10	0.87932	D	0	.	18.3719	0.90409	0.0:1.0:0.0:0.0	.	13;13	P01116-2;P01116	.;RASK_HUMAN	D	13	ENSP00000308495:G13D;ENSP00000452512:G13D;ENSP00000256078:G13D;ENSP00000451856:G13D	ENSP00000256078:G13D	G	-	2	0	KRAS	25289548	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	7.743000	0.85020	2.668000	0.90789	0.563000	0.77884	GGC	KRAS-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000412230.1	5.814106	KEEP		-	7.491566	0.176471	3	14	---	---	---	---	1	0.9827065	23	27	0	27	3	15	0	34	2	TP
NF1	4763	broad.mit.edu	37	17	29509634	29509634	+	Missense_Mutation	SNP	T	T	C			STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	g.chr17:29509634T>C	ENST00000358273.4	+	8	1222	c.839T>C	c.(838-840)aTa>aCa	p.I280T	NF1_ENST00000356175.3_Missense_Mutation_p.I280T|NF1_ENST00000431387.4_Missense_Mutation_p.I280T	NM_001042492.2	NP_001035957.1	P21359	NF1_HUMAN	neurofibromin 1	280		NA			actin cytoskeleton organization|adrenal gland development|artery morphogenesis|camera-type eye morphogenesis|cerebral cortex development|collagen fibril organization|forebrain astrocyte development|forebrain morphogenesis|heart development|liver development|MAPKKK cascade|metanephros development|myelination in peripheral nervous system|negative regulation of cell migration|negative regulation of endothelial cell proliferation|negative regulation of MAP kinase activity|negative regulation of MAPKKK cascade|negative regulation of neuroblast proliferation|negative regulation of oligodendrocyte differentiation|negative regulation of transcription factor import into nucleus|osteoblast differentiation|phosphatidylinositol 3-kinase cascade|pigmentation|positive regulation of adenylate cyclase activity|positive regulation of neuron apoptosis|Ras protein signal transduction|regulation of blood vessel endothelial cell migration|regulation of bone resorption|response to hypoxia|smooth muscle tissue development|spinal cord development|sympathetic nervous system development|visual learning|wound healing	axon|cytoplasm|dendrite|intrinsic to internal side of plasma membrane|nucleus	protein binding|Ras GTPase activator activity	p.0?(8)|p.?(4)	NF1/ACCN1(2)	autonomic_ganglia(12)|breast(11)|central_nervous_system(72)|cervix(6)|endometrium(12)|haematopoietic_and_lymphoid_tissue(59)|kidney(9)|large_intestine(39)|liver(1)|lung(80)|ovary(20)|pancreas(2)|prostate(2)|skin(8)|soft_tissue(249)|stomach(2)|thyroid(1)|upper_aerodigestive_tract(5)|urinary_tract(9)	599		all_cancers(10;1.29e-12)|all_epithelial(10;0.00347)|all_hematologic(16;0.00556)|Acute lymphoblastic leukemia(14;0.00593)|Breast(31;0.014)|Myeloproliferative disorder(56;0.0255)|all_lung(9;0.0321)|Lung NSC(157;0.0659)		UCEC - Uterine corpus endometrioid carcinoma (4;4.38e-05)|all cancers(4;1.64e-26)|Epithelial(4;9.15e-23)|OV - Ovarian serous cystadenocarcinoma(4;3.58e-21)|GBM - Glioblastoma multiforme(4;0.00146)		TGTCCAGAAATAATCCAGGAT	0.368		NA	"""D, Mis, N, F, S, O"""		"""neurofibroma, glioma"""	"""neurofibroma, glioma"""			Neurofibromatosis, type 1	TCGA GBM(6;<1E-08)|TSP Lung(7;0.0071)|TCGA Ovarian(3;0.0088)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	Neurofibromatosis type 1	17	17q12	4763	neurofibromatosis type 1 gene		O	12	Whole gene deletion(8)|Unknown(4)	soft_tissue(7)|autonomic_ganglia(3)|central_nervous_system(2)											99	84	89			NA	NA	17		NA											NA				29509634		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	NF1, von Recklinghausen disease, incl.: Hereditary Spinal Neurofibromatosis, Neurofibromatosis-Noonan syndrome	ENSG00000196712	HGNC:7765	NM_000267	Approved	uc002hgg.3	NA	O00662|Q14284|Q14930|Q9UMK3	ENST00000358273.4	37	CCDS42292.1	.	.	.	.	.	.	.	.	.	.	T	17.48	3.400015	0.62177	.	.	ENSG00000196712	ENST00000431387;ENST00000358273;ENST00000356175	T;T;T	0.68624	2.76;-0.34;-0.34	5.23	5.23	0.72850	Armadillo-type fold (1);	0.047839	0.85682	D	0.000000	T	0.79323	0.4426	M	0.68952	2.095	0.80722	D	1	P;D;P;P;D	0.53462	0.605;0.96;0.846;0.718;0.96	B;D;B;B;D	0.66979	0.13;0.948;0.218;0.275;0.923	T	0.80193	-0.1484	10	0.49607	T	0.09	.	15.1286	0.72503	0.0:0.0:0.0:1.0	.	280;280;280;280;280	E1P657;P21359-2;P21359;Q14931;P21359-3	.;.;NF1_HUMAN;.;.	T	280	ENSP00000412921:I280T;ENSP00000351015:I280T;ENSP00000348498:I280T	ENSP00000348498:I280T	I	+	2	0	NF1	26533760	1.000000	0.71417	1.000000	0.80357	0.993000	0.82548	7.153000	0.77428	1.990000	0.58119	0.459000	0.35465	ATA	NF1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256351.2	23.693474	KEEP		+	24.283152	0.333333	8	16	---	---	---	---	1	1	337	668	0	616	8	17	0	31	2	TP
SMAD2	4087	broad.mit.edu	37	18	45395727	45395727	+	Missense_Mutation	SNP	T	T	A			STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	g.chr18:45395727T>A	ENST00000402690.2	-	4	801	c.407A>T	c.(406-408)gAt>gTt	p.D136V	SMAD2_ENST00000587353.1_5'UTR|SMAD2_ENST00000262160.6_Missense_Mutation_p.D136V|SMAD2_ENST00000586040.1_Missense_Mutation_p.D106V|SMAD2_ENST00000356825.4_Missense_Mutation_p.D106V|SMAD2_ENST00000591214.1_Missense_Mutation_p.D106V	NM_001003652.3	NP_001003652.1	Q15796	SMAD2_HUMAN	SMAD family member 2	136	MH1.	NA			anterior/posterior pattern formation|cell fate commitment|common-partner SMAD protein phosphorylation|intracellular signal transduction|mesoderm formation|negative regulation of transcription, DNA-dependent|palate development|paraxial mesoderm morphogenesis|positive regulation of epithelial to mesenchymal transition|positive regulation of transcription from RNA polymerase II promoter|primary miRNA processing|regulation of binding|regulation of transforming growth factor beta receptor signaling pathway|response to cholesterol|SMAD protein complex assembly|transforming growth factor beta receptor signaling pathway|zygotic specification of dorsal/ventral axis	activin responsive factor complex|cytosol	activating transcription factor binding|co-SMAD binding|double-stranded DNA binding|I-SMAD binding|R-SMAD binding|sequence-specific DNA binding transcription factor activity|transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity|type I transforming growth factor beta receptor binding|ubiquitin protein ligase binding			breast(1)|central_nervous_system(2)|endometrium(4)|kidney(3)|large_intestine(21)|liver(1)|lung(8)|prostate(2)|urinary_tract(1)	43						ACTGTGAAGATCAGGCCAGCG	0.423		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													112	105	108			NA	NA	18		NA											NA				45395727		2203	4300	6503	SO:0001583	missense			ENSG00000175387	HGNC:6768	NM_005901	Approved	uc002lcz.4	NA		ENST00000402690.2	37	CCDS11934.1	.	.	.	.	.	.	.	.	.	.	T	20.7	4.029556	0.75504	.	.	ENSG00000175387	ENST00000262160;ENST00000356825;ENST00000402690	T;T;T	0.80909	-1.43;-1.43;-1.43	5.16	5.16	0.70880	MAD homology, MH1 (3);MAD homology 1, Dwarfin-type (2);	0.000000	0.85682	D	0.000000	D	0.85500	0.5711	M	0.84433	2.695	0.80722	D	1	B;P;B	0.36065	0.289;0.535;0.289	B;B;B	0.42653	0.33;0.394;0.33	D	0.87690	0.2553	10	0.87932	D	0	.	15.2805	0.73781	0.0:0.0:0.0:1.0	.	106;106;136	B7Z5N5;Q15796-2;Q15796	.;.;SMAD2_HUMAN	V	136;106;136	ENSP00000262160:D136V;ENSP00000349282:D106V;ENSP00000384449:D136V	ENSP00000262160:D136V	D	-	2	0	SMAD2	43649725	1.000000	0.71417	1.000000	0.80357	0.991000	0.79684	7.997000	0.88414	2.070000	0.61991	0.477000	0.44152	GAT	SMAD2-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000450571.1	40.608605	KEEP		-	41.974585	0.319149	15	32	---	---	---	---	1	1	120	159	0	179	15	35	0	50	2	TP
SERPINB8	5271	broad.mit.edu	37	18	61654234	61654234	+	Missense_Mutation	SNP	C	C	A			STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4H3-Tumor-SM-3UUPV	STAD-TCGA-HU-A4H3-Normal-SM-3UURI	g.chr18:61654234C>A	ENST00000397985.2	+	7	1103	c.847C>A	c.(847-849)Ctt>Att	p.L283I	SERPINB8_ENST00000493661.1_Intron|SERPINB8_ENST00000353706.2_Missense_Mutation_p.L283I|SERPINB8_ENST00000542677.1_Missense_Mutation_p.L101I	NM_001276490.1	NP_001263419.1	P50452	SPB8_HUMAN	serpin peptidase inhibitor, clade B (ovalbumin), member 8	283		NA			regulation of proteolysis	cytosol	protein binding|serine-type endopeptidase inhibitor activity			breast(2)|kidney(1)|large_intestine(4)|lung(9)|skin(1)	17		Esophageal squamous(42;0.129)				GGAGCCTTTCCTTCGAAGATT	0.423		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													110	105	107			NA	NA	18		NA											NA				61654234		2203	4300	6503	SO:0001583	missense			ENSG00000166401	HGNC:8952	NM_001031848	Approved	uc002lju.3	NA	Q7Z2V6	ENST00000397985.2	37	CCDS11991.1	.	.	.	.	.	.	.	.	.	.	C	19.70	3.876444	0.72180	.	.	ENSG00000166401	ENST00000397985;ENST00000353706;ENST00000542677	D;D;D	0.95035	-3.59;-3.59;-3.59	5.65	4.78	0.61160	Serpin domain (3);	0.057300	0.64402	D	0.000001	D	0.97907	0.9312	H	0.96015	3.755	0.58432	D	0.999995	D	0.59357	0.985	D	0.71656	0.974	D	0.98586	1.0652	10	0.87932	D	0	.	11.8985	0.52669	0.0:0.8564:0.0:0.1436	.	283	P50452	SPB8_HUMAN	I	283;283;101	ENSP00000381072:L283I;ENSP00000331368:L283I;ENSP00000438328:L101I	ENSP00000331368:L283I	L	+	1	0	SERPINB8	59805214	0.006000	0.16342	0.490000	0.27465	0.896000	0.52359	0.162000	0.16501	1.630000	0.50440	0.655000	0.94253	CTT	SERPINB8-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000134014.1	55.241208	KEEP		+	58.664942	0.276316	21	55	---	---	---	---	1	1	52	99	0	119	27	56	0	118	2	TP
